Mirati Therapeutics Prices 3.25M Share Offering at $17.50/Share

By: Benzinga
Mirati Therapeutics (NASDAQ: MRTX) today announced the pricing of an underwritten public offering of 3,250,000 shares of its common stock at a price to the public of $17.50 per share. The gross proceeds from this offering to Mirati are expected to be approximately $56.9 million, before deducting underwriting discounts and
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.